COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile
Abstract
Highlights 1. Several publications address MS considerations for the current COVID-19 pandemic 2. Results from a short online questionnaire from 280 MS patients are reported 3. Three-quarters of the patients implemented early remote-working 4. Most patients (95%) are on immunomodulatory therapy 5. Three patients were infected with COVID-19 with good recovery
Más información
Título de la Revista: | Multiple Sclerosis and Related Disorders |
Volumen: | 42 |
Editorial: | Elsevier B.V. |
Fecha de publicación: | 2020 |
Página de inicio: | 102204 |
DOI: |
10.1016/j.msard.2020.102204 |